Cytek Biosciences (CTKB)
NASDAQ:CTKB
Holding CTKB?
Track your performance easily

Cytek Biosciences (CTKB) Balance Sheet

46 Followers

Cytek Biosciences Balance Sheet

Cytek Biosciences's total assets for Q3 2024 were $491.23M, an increase of 1.55% from the previous quarter. CTKB total liabilities were $105.76M for the fiscal quarter, a 11.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 494.46M$ 519.48M$ 463.31M$ 219.98M$ 70.36M
Total Liabilities
$ 101.39M$ 93.93M$ 57.92M$ 236.01M$ 112.06M
Total Equity Gross Minority
$ 393.06M$ 425.55M$ 405.38M$ -16.03M$ -41.70M
Total Capitalization
$ 405.84M$ 442.40M$ 405.38M$ -16.03M$ -41.70M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Cytek Biosciences Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis